• Profile
Close

Effects of exercise therapy dosing schedule on impaired cardiorespiratory fitness in patients with primary breast cancer: A randomized controlled trial

Circulation Feb 28, 2020

Scott JM, Thomas SM, Peppercorn JM, et al. - Researchers undertook a parallel-group randomized trial with patients with posttreatment primary breast cancer, to determine the tolerability as well as the efficacy of 2 exercise training dose regimens on cardiorespiratory fitness and patient-reported outcomes in this patient population. Random assignment of 174 postmenopausal patients (2.8 years post-adjuvant therapy) with impaired peak oxygen consumption (VO2peak) was done to 1 of 2 supervised exercise training interventions delivered with a standard linear (LET) (fixed dose intensity per session for 160 min/wk) or nonlinear (NLET) (variable dose intensity per session for ≈120 min/wk) schedule relative to a stretching attention control group for 16 consecutive weeks. They found a rise in VO2peak in LET and NLET, which was 0.6 ± 1.7 mL O2·kg−1·min−1 and 0.8 ± 1.8 mL O2·kg−1·min−1, respectively, compared with attention control, in the intention-to-treat analysis. Relative to attention control, NLET caused an improvement in all patient-reported outcomes. Overall, among patients previously treated for early-stage breast cancer, modest improvements in cardiorespiratory fitness were observed in correlation with short-term exercise training, independently of the dosing schedule.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay